890 related articles for article (PubMed ID: 6234178)
1. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
2. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
[TBL] [Abstract][Full Text] [Related]
3. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
Karoum F; Suddath RL; Wyatt RJ
Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
[TBL] [Abstract][Full Text] [Related]
4. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain.
Fujita K; Kobayashi A; Suzuki S; Nakazawa K
Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
6. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
[TBL] [Abstract][Full Text] [Related]
7. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythms in catecholamine metabolites and cyclic nucleotide production.
Kafka MS; Benedito MA; Roth RH; Steele LK; Wolfe WW; Catravas GN
Chronobiol Int; 1986; 3(2):101-15. PubMed ID: 2824067
[TBL] [Abstract][Full Text] [Related]
10. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
Handa RJ; Hejna GM; Lorens SA
Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ethanol and low-carbohydrate diet on contents of noradrenaline, dopamine, serotonin and their metabolites in rat brain].
Hirose T
Nihon Eiseigaku Zasshi; 1991 Aug; 46(3):755-61. PubMed ID: 1720179
[TBL] [Abstract][Full Text] [Related]
12. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
Heidbreder C; Gewiss M; De Potter W; De Witte P
Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678
[TBL] [Abstract][Full Text] [Related]
13. Methyl bromide alters catecholamine and metabolite concentrations in rat brain.
Honma T; Miyagawa M; Sato M
Neurotoxicol Teratol; 1987; 9(5):369-75. PubMed ID: 2447477
[TBL] [Abstract][Full Text] [Related]
14. Changes in monoamines and their metabolite levels in some brain regions of aged rats.
Ponzio F; Calderini G; Lomuscio G; Vantini G; Toffano G; Algeri S
Neurobiol Aging; 1982; 3(1):23-9. PubMed ID: 6178985
[TBL] [Abstract][Full Text] [Related]
15. Reduction of norepinephrine turnover by serotonergic drug in man.
Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.
Masana MI; Heyes MP; Mefford IN
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):609-21. PubMed ID: 2236587
[TBL] [Abstract][Full Text] [Related]
17. Effect of aging on monoamines and their metabolites in the rat brain.
Moretti A; Carfagna N; Trunzo F
Neurochem Res; 1987 Nov; 12(11):1035-9. PubMed ID: 2446157
[TBL] [Abstract][Full Text] [Related]
18. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
Guldberg HC; Yates CM
Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Dunn AJ; Berridge CW
Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
Gottberg E; Grondin L; Reader TA
J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
